J Endocr Soc 5(9):bvab118 Doggrell SA (2023) Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, a step forward in the treatment of diabetes and obesity
They help regulate appetite, slow stomach emptying, and improve blood sugar control, which can support weight loss in people who are obese or overweight with health conditions
Next-generation molecules Newer molecules entering the GLP-1 space, including GLP-3 peptides , mazdutide , survodutide , and orforglipron , each have unique pharmacokinetic profiles that will require their own timing optimization strategies
With a molecular weight of approximately 4731 g/mol and a molecular formula of C221H342N46O68 (though some sources note C223H343F3N46O70 due to trifluoroacetate salt variations), Retatrutides structure supports its role as a triple agonist targeting glucagon (GCGR), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon-like peptide-1 (GLP-1R) receptors
Dehydration can worsen fatigue, dizziness, constipation, and weakness